Improving the preclinical models for the study of chemotherapy-induced cardiotoxicity: a Position Paper of the Italian Working Group on Drug Cardiotoxicity and Cardioprotection.
about
Drug-induced mitochondrial dysfunction and cardiotoxicity.Cancer Therapy-Related Cardiac Dysfunction and Heart Failure: Part 2: Prevention, Treatment, Guidelines, and Future Directions.VEGF-B gene therapy inhibits doxorubicin-induced cardiotoxicity by endothelial protection.Microdosing and Other Phase 0 Clinical Trials: Facilitating Translation in Drug Development.Current views on anthracycline cardiotoxicity.Integrated cardiovascular safety: multifaceted considerations in drug development and therapeutic use.Signalling mechanisms underlying doxorubicin and Nox2 NADPH oxidase-induced cardiomyopathy: involvement of mitofusin-2.Timing of the negative effects of trastuzumab on cardiac mechanics after anthracycline chemotherapy.Breakthroughs in modern cancer therapy and elusive cardiotoxicity: Critical research-practice gaps, challenges, and insights.Antineoplastic Drug-Induced Cardiotoxicity: A Redox Perspective.
P2860
Q36339445-EFDF05D8-372F-4E2D-9D16-4E5BCDCC6E9BQ36551901-6E934FEE-9146-43CD-889A-B81079B9A23BQ37469455-A42ABC43-CD55-42F5-91B5-632ABC83E72CQ37701128-85834B88-C1E7-49DF-94D2-233DFBF35645Q38845535-13477076-9675-43CC-B957-F97776278F18Q39164190-49593516-C948-4271-BCD3-4BC2B4601A6BQ42678476-EE2B218F-F5BF-40EF-967B-285CC18B13C7Q48325287-540441F1-C27F-4A2D-80AD-3869F156DABEQ49315568-C4E46E17-80D4-4ED4-9A08-C3BDDD850E4CQ51760757-3B24E79C-C654-4F19-BF15-D8626A74D44B
P2860
Improving the preclinical models for the study of chemotherapy-induced cardiotoxicity: a Position Paper of the Italian Working Group on Drug Cardiotoxicity and Cardioprotection.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Improving the preclinical mode ...... toxicity and Cardioprotection.
@en
type
label
Improving the preclinical mode ...... toxicity and Cardioprotection.
@en
prefLabel
Improving the preclinical mode ...... toxicity and Cardioprotection.
@en
P2093
P2860
P50
P1476
Improving the preclinical mode ...... otoxicity and Cardioprotection
@en
P2093
Alessia Pepe
Concetta Zito
Paolo Spallarossa
P2860
P2888
P304
P356
10.1007/S10741-015-9497-4
P50
P577
2015-09-01T00:00:00Z